Cellular Origins and Fresenius Kabi have completed the first phase of a CGT manufacturing collaboration announced in October 2024.
Researchers have completed the first phase of a collaboration integrating robotic cell processing with automated ...
CAMBRIDGE, England & STEVENAGE, England--(BUSINESS WIRE)--Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and ...
Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs ...
Reducing manual touchpoints is an important part of supporting more consistent and scalable manufacturing processes.
Expanded capabilities leverage GE Vernova’s Grid Automation solutions to support North American electric utilities modernizing communications infrastructure ...
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results